MX344174B - Uso de un dispositivo y kit para el diagnostico de enfermedades neuropsiquiatricas a partir del neuroepitelio olfatorio. - Google Patents

Uso de un dispositivo y kit para el diagnostico de enfermedades neuropsiquiatricas a partir del neuroepitelio olfatorio.

Info

Publication number
MX344174B
MX344174B MX2011000500A MX2011000500A MX344174B MX 344174 B MX344174 B MX 344174B MX 2011000500 A MX2011000500 A MX 2011000500A MX 2011000500 A MX2011000500 A MX 2011000500A MX 344174 B MX344174 B MX 344174B
Authority
MX
Mexico
Prior art keywords
diagnosis
kit
neuropsychiatric diseases
olfactory neuroepithelium
neuroepithelium
Prior art date
Application number
MX2011000500A
Other languages
English (en)
Other versions
MX2011000500A (es
Inventor
A Benítez King Gloria
B Ramírez Rodríguez Gerardo
Ortíz López Leonardo
Riquelme Sandoval Agustín
Parra Cervantes Patricia
Soto Vázquez Ramón
Romero Castello Samuel
Original Assignee
Inst Nac De Psiquiatria Ramon De La Fuente Muñiz *
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nac De Psiquiatria Ramon De La Fuente Muñiz * filed Critical Inst Nac De Psiquiatria Ramon De La Fuente Muñiz *
Priority to MX2011000500A priority Critical patent/MX344174B/es
Publication of MX2011000500A publication Critical patent/MX2011000500A/es
Priority to PCT/MX2012/000004 priority patent/WO2012096557A2/es
Publication of MX344174B publication Critical patent/MX344174B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/02—Instruments for taking cell samples or for biopsy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5038—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving detection of metabolites per se
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5058—Neurological cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/02—Instruments for taking cell samples or for biopsy
    • A61B2010/0216—Sampling brushes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/30—Psychoses; Psychiatry

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a un kit para el diagnóstico de enfermedades neuropsiquiátricas a partir de precursores neuronales obtenidos de la región turbinada manera no invasiva, caracterizado porque comprende: a) un dispositivo con cerdas helicoidales b) una o más soluciones para el tratamiento de la muestra seleccionadas del grupo que comprende: i. Soluciones que contienen medio de cultivo para precursores nueronales. ii. Soluciones humectantes y separadora de células neuronales. iii. Solución que romper proteínas y dispersa células neuronales. iv . Solución fijadora de células neuronales. v. Solución criopreservadora de células neuronales. vi. Solución de mantenimiento y diferenciadora de precursores neuronales. vii. Solución identificadora de moléculas proteicas específicas de precursores y células neuronales. viii. Solución marcadora de moléculas proteicas específicas de precursores y células neuronales. c) Uno o más dispositivos y/o soportes para el desarrollo y mantenimientos de las células obtenidas de la cavidad nasal, y d) Uno o más manuales de procedimientos de toma de muestra, propagación y mantenimiento de las células, procesamiento e interpretación adecuada de los resultados obtenidos por el procesamiento de las muestras.
MX2011000500A 2011-01-13 2011-01-13 Uso de un dispositivo y kit para el diagnostico de enfermedades neuropsiquiatricas a partir del neuroepitelio olfatorio. MX344174B (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MX2011000500A MX344174B (es) 2011-01-13 2011-01-13 Uso de un dispositivo y kit para el diagnostico de enfermedades neuropsiquiatricas a partir del neuroepitelio olfatorio.
PCT/MX2012/000004 WO2012096557A2 (es) 2011-01-13 2012-01-12 Uso de un dispositivo y kit para el diagnóstico de enfermedades neuropsiquiátricas a partir del neuroepitelio olfatorio

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2011000500A MX344174B (es) 2011-01-13 2011-01-13 Uso de un dispositivo y kit para el diagnostico de enfermedades neuropsiquiatricas a partir del neuroepitelio olfatorio.

Publications (2)

Publication Number Publication Date
MX2011000500A MX2011000500A (es) 2011-05-04
MX344174B true MX344174B (es) 2016-12-08

Family

ID=44676215

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011000500A MX344174B (es) 2011-01-13 2011-01-13 Uso de un dispositivo y kit para el diagnostico de enfermedades neuropsiquiatricas a partir del neuroepitelio olfatorio.

Country Status (2)

Country Link
MX (1) MX344174B (es)
WO (1) WO2012096557A2 (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5726060A (en) * 1991-09-17 1998-03-10 Bridges; Michael Anthony Method for culturing mammalian respiratory epithelial cells
ES2255322T3 (es) * 1998-12-02 2006-06-16 Mdz Beheer B.V. Cepillo apropiado para la toma de un frotis.

Also Published As

Publication number Publication date
WO2012096557A2 (es) 2012-07-19
WO2012096557A3 (es) 2012-10-04
MX2011000500A (es) 2011-05-04

Similar Documents

Publication Publication Date Title
IL274469A (en) Compositions, uses and methods for the treatment of metabolic disorders and diseases
EA201891833A1 (ru) Комбинация для лечения амиотрофического бокового склероза или родственных болезней
GB2492487B (en) Cannabinoids for use in the treatment of neurodegenerative diseases or disorders
AU2012205878A8 (en) miRNA for treating diseases and conditions associated with neo-angiogenesis
MX2021007268A (es) Formas solidas de acido {[5-(3-clorofenil)-3-hidroxipiridin-2-carb onil]amino}acetico, composiciones, y usos de las mismas.
BR112013020798A2 (pt) terapia de combinação do inibidor mtor /jak
IL216509A0 (en) Use of an anti-tau ps422 antibody for the treatment of brain diseases
MX2012003770A (es) Metodos para la modulacion de autofagia a traves de la modulacion de productos de genes que aumentan la autofagia.
UY33863A (es) Metodos y medicamentos para el tratamiento de la enfermedad de alzheimer
MY164579A (en) Safe and functional humanized antibodies
MX356728B (es) Combinación farmacéutica para usar en el tratamiento de pacientes que padecen diabetes de tipo 2.
EA201390948A1 (ru) Лечение боли, обусловленной смещением базального слоя эндометрия
MX349224B (es) Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa.
PL2771329T3 (pl) Nowe związki di-podstawione 3,4-diamino-3-cyklobuteno- 1,2-dionu do zastosowania w leczeniu patologii, w których pośredniczą chemokiny
MX2013008077A (es) Mejora de estructura para accesorio de manufactura de zapato convenientemente ajustable y reemplazable.
MX2013011124A (es) Compuestos para el tratamiento del sindrome metabolico.
LTPA2020511I1 (lt) Ciklezonidas, skirtas arklių kvėpavimo takų ligų gydymui
IN2014CN03854A (es)
MX357656B (es) Alfa-1-microglobulina para usarse en tratamiento de enfermedades relacionadas a mitocondrias.
CR20120247A (es) Canfenos arilados novedosos, procesos para su preparación y usos
MX2014001393A (es) 3-(bifenil-3-il)-4-hidroxi-8-metoxi-1-azaespiro[4.5]dec-3-en-2-on as sustituidas.
MX340536B (es) Terapia direccionada al receptor del factor de crecimiento epidermico (egfr).
CA2851761C (en) Method of diagnosis, prognostic or treatment of neurodegenerative diseases
MD20160109A2 (ro) Compuşi heteroaromatici şi utilizarea lor ca liganzi ai dopaminei D1
EA201200855A1 (ru) Модуляторы crth2

Legal Events

Date Code Title Description
FG Grant or registration